Acrivon Therapeutics, Inc. Common Stock (ACRV) NASDAQ
1.94
-0.035(-1.78%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
1.94
-0.035(-1.78%)
Currency In USD
| Market Cap | 92.81M |
| Enterprise Value | 54.02M |
| P/E Ratio | -0.96 |
| PEG Ratio | -0.05 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 0.66 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -0.26 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.6 |
| Return On Equity | -0.57 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -1.36M |
| EBITDA | -82.76M |
| Net Income | -77.91M |
| Diluted EPS | -2.02 |
| Total Cash | 118.58M |
| Total Cash/Share | 3.08 |
| Total Debt | 2.71M |
| Total Debt/Equity | 0.02 |
| Current Ratio | 7.69 |
| Book Value Per Share | 2.92 |
| 52-Week Change | -3.25 |
| 52-Week High | 3.56 |
| 52-Week Low | 1.05 |
| Moving Average 50 Days | 1.6 |
| Moving Average 200 Days | 1.78 |
| Average Volume | 850,113 |
| Shares Outstanding | 31.56M |
| % Held by Institutions | 48.26 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |